why choose us

First received: November 20, 2023

Clinical Trial: Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Type 2 Diabetes

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Multicenter, Randomised, Paralleled, Placebo-controlled (Double-blind) and Active Drug-controlled (Open) Study to Investigate Efficacy and Safety of HEC88473 Injection in Subjects With Type

Brief Summary: This is a multicenter, randomized, parallel, placebo- and active comparator-controlled phase 2 trial to evaluate the efficacy, safety, pharmacokinetics and immunogenicity in subjects with T2DM.Patients treated with diet and exercise alone, or in combination with stable metformin monotherapy (?1500 mg/day or maximum tolerated dose ?1000 mg/ day.), will be enrolled.Approximately 225 participants will be randomized.The study includes four stages: screening period (up to 2 weeks), lead-in period (2 weeks),…

Read more